Concise communication title: wide adoption of rapid molecular detection of antimicrobial resistance markers for use with blood cultures: implications for national surveillance of antimicrobial resistance
Rapid molecular testing for antimicrobial resistance (AR) provides an indication of resistance faster than phenotypic antimicrobial susceptibility testing. We summarize the adoption of molecular testing for AR among US acute care hospitals and discuss the potential impact on National Healthcare Safety Network's surveillance for AR.
Authors
- Reg England
- Marissa McMeen (ORCID: https://orcid.org/0009-0009-6747-9398)
- Andrea L. Benin (ORCID: https://orcid.org/0000-0003-2765-6272)
- Hsiu Wu (ORCID: https://orcid.org/0000-0002-4195-7162)
- Joseph D. Lutgring (ORCID: https://orcid.org/0000-0001-5723-8317)
- Amy Webb (ORCID: https://orcid.org/0000-0002-8256-3995)
- Virgie Fields (ORCID: https://orcid.org/0000-0001-7198-1182)
- Xiaoluo Huang (ORCID: https://orcid.org/0009-0006-1166-6838)
- John Spinosa (ORCID: https://orcid.org/0009-0003-2395-5934)
Institutions
- Leidos (United States) (US)
- Oak Ridge Associated Universities (US)
- Hyattsville Community Development Corporation (US)
- Office of Minority Health and Health Equity (US)
- Scientific Consulting Group (US)
- Oak Ridge Institute for Science and Education
Publication Details
- Journal
- Infection Control and Hospital Epidemiology
- Published
- 2025-11-06
- DOI
- https://doi.org/10.1017/ice.2025.67
- Primary Topic
- Bacterial Identification and Susceptibility Testing
- Type
- article
- Field-Weighted Citation Impact
- 0.00